177Lu-lilotomab satetraxetan has the potential to counteract resistance to rituximab in non- Hodgkin's lymphoma.
| Autor: | Malenge, Marion M., Patzke, Sebastian, Ree, Anne H., Stokke, Trond, Ceuppens, Peter, Middleton, Brian, Dahle, Jostein, Repetto-Llamazares, Ada H. V. |
|---|---|
| Zdroj: | Journal of Nuclear Medicine; Dec2020, Vol. 61 Issue 12, p1-36, 36p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|